Table 5.
Comparisons of spot urine creatinine-to-osmolality ratio according to conditions of demographics, comorbidities, and medication use.
| sUCr/Osm Mean ± SD |
P value | |
|---|---|---|
| Sex | ||
| Male vs. female | 0.20 ± 0.09 vs. 0.17 ± 0.08 | <0.001 |
| Races | ||
| Mexican American | 0.17 ± 0.07 | <0.001a |
| Other Hispanic | 0.17 ± 0.07 | |
| Non-Hispanic White | 0.18 ± 0.08 | |
| Non-Hispanic Black | 0.23 ± 0.10 | |
| Non-Hispanic Asian | 0.16 ± 0.07 | |
| Other races | 0.19 ± 0.08 | |
| African American (yes vs. no) | 0.23 ± 0.10 vs. 0.18 ± 0.07 | <0.001 |
| Comorbidities (yes vs. no) | ||
| Hypertension | 0.19 ± 0.09 vs. 0.19 ± 0.08 | 0.054 |
| Diabetes mellitus | 0.18 ± 0.09 vs. 0.19 ± 0.08 | 0.123 |
| Coronary artery disease | 0.20 ± 0.08 vs. 0.19 ± 0.08 | 0.199 |
| Congestive heart failure | 0.21 ± 0.09 vs. 0.19 ± 0.08 | 0.104 |
| Cerebrovascular disease | 0.20 ± 0.11 vs. 0.19 ± 0.08 | 0.305 |
| Active liver disease | 0.18 ± 0.09 vs. 0.19 ± 0.08 | 0.240 |
| Cancer | 0.18 ± 0.08 vs. 0.19 ± 0.08 | 0.080 |
| Medication use (yes vs. no) | ||
| ACEI/ARB | 0.19 ± 0.10 vs. 0.19 ± 0.08 | 0.186 |
| β-Adrenergic blocker | 0.20 ± 0.10 vs. 0.19 ± 0.08 | 0.027 |
| Calcium channel blocker | 0.22 ± 0.12 vs. 0.19 ± 0.08 | <0.001 |
| Diuretics | 0.20 ± 0.10 vs. 0.19 ± 0.08 | 0.315 |
| Other antihypertensives | 0.22 ± 0.10 vs. 0.19 ± 0.08 | 0.002 |
Abbreviations: ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin II receptor blocker; sUCr/Osm: spot urine creatinine-to-osmolality ratio. aAs indicated, a comparison for the means among the various ethnic groups is performed using the one-way analysis of variance (ANOVA) along with the Bonferroni method as the post hoc test.